Abstract:Abstract Genomic instability is the hallmark of various cancers with the increasing accumulation of DNA damage. The application of radiotherapy and chemotherapy in cancer treatment is typically based on this property of cancers. However, the adverse effects including normal tissues injury are also accompanied by the radiotherapy and chemotherapy. Targeted cancer therapy has the potential to suppress cancer cells’ DNA damage response through tailoring therapy to cancer patients lacking specific DNA damage response functions. Obviously, understanding the broader role of DNA damage repair in cancers has became a basic and attractive strategy for targeted cancer therapy, in particular, raising novel hypothesis or theory in this field on the basis of previous scientists’ findings would be important for future promising druggable emerging targets. In this review, we first illustrate the timeline steps for the understanding the roles of DNA damage repair in the promotion of cancer and cancer therapy developed, then we summarize the mechanisms regarding DNA damage repair associated with targeted cancer therapy, highlighting the specific proteins behind targeting DNA damage repair that initiate functioning abnormally duo to extrinsic harm by environmental DNA damage factors, also, the DNA damage baseline drift leads to the harmful intrinsic targeted cancer therapy. In addition, clinical therapeutic drugs for DNA damage and repair including therapeutic effects, as well as the strategy and scheme of relative clinical trials were intensive discussed. Based on this background, we suggest two hypotheses, namely “environmental gear selection” to describe DNA damage repair pathway evolution, and “DNA damage baseline drift”, which may play a magnified role in mediating repair during cancer treatment. This two new hypothesis would shed new light on targeted cancer therapy, provide a much better or more comprehensive holistic view and also promote the development of new research direction and new overcoming strategies for patients.

Dual Targeting of DNA Damage Response Proteins Implicated in Cancer Radioresistance

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer

Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons

Perspectives on the Combination of Radiotherapy and Targeted Therapy with DNA Repair Inhibitors in the Treatment of Pancreatic Cancer.

Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy

Harnessing The Targeting Potential Of Differential Radiobiological Effects Of Photon Versus Particle Radiation For Cancer Treatment

Cancer Chemoradiotherapy Duo: Nano-Enabled Targeting of DNA Lesion Formation and DNA Damage Response.

Inhibition of key DNA double strand break repair protein kinases enhances radiosensitivity of head and neck cancer cells to X-ray and proton irradiation

DNA Damage and Its Role in Cancer Therapeutics

DNA Repair Inhibition: a Selective Tumour Targeting Strategy.

DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

Dual Targeting of Akt and mTORC1 Impairs Repair of DNA Double-Strand Breaks and Increases Radiation Sensitivity of Human Tumor Cells

Cancer Radiosensitizers.

The Cellular Response to Complex DNA Damage Induced by Ionising Radiation

Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break Repair

Emerging strategies to target cancer metabolism and improve radiation therapy outcomes

Strategies for targeting the DNA damage response for cancer therapeutics.

Targeting DNA damage response pathways in cancer